Products - Dementia | Topic | NICE

Showing 1 product

Date | Title

Guidance programme: Technology appraisal guidanceRemove ‘Guidance programme: Technology appraisal guidance’ filter
Status: PublishedRemove ‘Status: Published’ filter

Donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer's disease (TA217)
Product type:
Guidance
Programme:
Technology appraisal guidance
Last updated:
20 June 2018
Published:
23 March 2011